RxDoctor Payments Data

Xiaoyang Hua, MD

Otolaryngology · Houston, TXNPI 1780942946

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,717 of the $11,509 with a category attached, or 84.4%. Insmed, Inc. accounts for 84.4% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $5,494, more than ten times the $181 reported in 2019. Among otolaryngology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$11,509in general payments, 2019–2025

Across 19 payments — averaging $605.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Insmed, Inc.$10K
  • Med-el Corporation$1K
  • Aerin Medical Inc.$311
  • Smith+Nephew$181
  • Inspire Medical Systems, Inc.$105
  • Cochlear Americas$88
  • plus $77 from 2 others

What the payments were for

  • Consulting fees$9,71784%
  • Travel & lodging$7887%
  • Food & beverage$8337%
  • Education$1701%

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,509 in reported general payments places this provider in the 90th percentile of 729 otolaryngology providers in Texas.

See all otolaryngology providers in Texas →

Medicare billing

Part B allowed, 2024
$22,229
Medicare patients
75
Services billed
177

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth36$3,967
Ofloxacin28$692
Fluocinolone Acetonide Oil12$359
Fluticasone Propionate29$290
Azelastine Hcl16$212

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Houston

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →